BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 15466641)

  • 1. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
    Bendall JK; Damy T; Ratajczak P; Loyer X; Monceau V; Marty I; Milliez P; Robidel E; Marotte F; Samuel JL; Heymes C
    Circulation; 2004 Oct; 110(16):2368-75. PubMed ID: 15466641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of beta 3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide.
    Birenbaum A; Tesse A; Loyer X; Michelet P; Andriantsitohaina R; Heymes C; Riou B; Amour J
    Anesthesiology; 2008 Dec; 109(6):1045-53. PubMed ID: 19034101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats.
    Damy T; Ratajczak P; Robidel E; Bendall JK; OliviƩro P; Boczkowski J; Ebrahimian T; Marotte F; Samuel JL; Heymes C
    FASEB J; 2003 Oct; 17(13):1934-6. PubMed ID: 12897062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
    Amour J; Loyer X; Le Guen M; Mabrouk N; David JS; Camors E; Carusio N; Vivien B; Andriantsitohaina R; Heymes C; Riou B
    Anesthesiology; 2007 Sep; 107(3):452-60. PubMed ID: 17721248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocardial effects of nitric oxide, NO. Clinical and experimental evidence].
    Heymes C; Swynghedauw B; Samuel JL
    Bull Acad Natl Med; 2005 May; 189(5):893-901; discussion 901. PubMed ID: 16433461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases.
    Khan SA; Skaf MW; Harrison RW; Lee K; Minhas KM; Kumar A; Fradley M; Shoukas AA; Berkowitz DE; Hare JM
    Circ Res; 2003 Jun; 92(12):1322-9. PubMed ID: 12764022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury.
    Li D; Qu Y; Tao L; Liu H; Hu A; Gao F; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ
    J Surg Res; 2006 Mar; 131(1):64-72. PubMed ID: 16154595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium.
    Saraiva RM; Minhas KM; Raju SV; Barouch LA; Pitz E; Schuleri KH; Vandegaer K; Li D; Hare JM
    Circulation; 2005 Nov; 112(22):3415-22. PubMed ID: 16301341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.
    Dawson D; Lygate CA; Zhang MH; Hulbert K; Neubauer S; Casadei B
    Circulation; 2005 Dec; 112(24):3729-37. PubMed ID: 16344403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients.
    Ziolo MT; Maier LS; Piacentino V; Bossuyt J; Houser SR; Bers DM
    Circulation; 2004 Apr; 109(15):1886-91. PubMed ID: 15037528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes.
    Ashley EA; Sears CE; Bryant SM; Watkins HC; Casadei B
    Circulation; 2002 Jun; 105(25):3011-6. PubMed ID: 12081996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
    Smith JM; Paulson DJ; Romano FD
    J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.
    Barouch LA; Harrison RW; Skaf MW; Rosas GO; Cappola TP; Kobeissi ZA; Hobai IA; Lemmon CA; Burnett AL; O'Rourke B; Rodriguez ER; Huang PL; Lima JA; Berkowitz DE; Hare JM
    Nature; 2002 Mar; 416(6878):337-9. PubMed ID: 11907582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3.
    Champion HC; Georgakopoulos D; Takimoto E; Isoda T; Wang Y; Kass DA
    Circ Res; 2004 Mar; 94(5):657-63. PubMed ID: 14752030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inotropic response of cardiac ventricular myocytes to beta-adrenergic stimulation with isoproterenol exhibits diurnal variation: involvement of nitric oxide.
    Collins HE; Rodrigo GC
    Circ Res; 2010 Apr; 106(7):1244-52. PubMed ID: 20167926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
    Shinke T; Shite J; Takaoka H; Hata K; Inoue N; Yoshikawa R; Matsumoto H; Masai H; Watanabe S; Ozawa T; Otake H; Matsumoto D; Hirata K; Yokoyama M
    Am Heart J; 2007 Oct; 154(4):645.e1-8. PubMed ID: 17892985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
    Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
    J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure.
    Gealekman O; Abassi Z; Rubinstein I; Winaver J; Binah O
    Circulation; 2002 Jan; 105(2):236-43. PubMed ID: 11790707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction.
    Massion PB; Dessy C; Desjardins F; Pelat M; Havaux X; Belge C; Moulin P; Guiot Y; Feron O; Janssens S; Balligand JL
    Circulation; 2004 Oct; 110(17):2666-72. PubMed ID: 15492314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.